immunotherapy Applications
-
Microbiome Therapeutics for Patients and Physicians
Seres’ microbiome therapeutics represent a transformative new approach to ...
By Seres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Next generation immune sequencing for infectious disease
associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single ...
By iRepertoire, Inc. based in Huntsville, ALABAMA (USA).
-
TCR and BCR insights for immuno-oncology industry
associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single ...
By iRepertoire, Inc. based in Huntsville, ALABAMA (USA).
-
Immunoscore for IC in Lung Cancer
IMMUNOSCORE® IC is intended for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
Proprietary Technologies for Approach Towards Cancer
With the development and commercialization of immunotherapy drugs such as checkpoint ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Solutions for benchtop single cell sorting and dispensing sector
High Performance Across the Breadth of Biotech. The NX One is a perfect fit for a wide variety of sectors and application areas spanning fundamental biological research to industrial and clinical workflows. Access your cells faster and at a fraction of the ...
By Nodexus Inc. based in Hayward, CALIFORNIA (USA).
-
Highly customized aptamer discovery solutions for therapeutic aptamers sector
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
NK-cell Therapy - Ushering in the Future of NK-cell Therapy
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
By Kiadis Pharma NV based in Amsterdam, NETHERLANDS.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you